Nonalcoholic steatohepatitis (NASH) drugs market

被引：54
|
作者：
Cassidy, Sorcha [1 ]
Syed, Basharut A. [1 ]
机构：
[1] PSL Grp, FirstWord Pharma, 75 Davies St, London W1K 5JN, England
来源：
NATURE REVIEWS DRUG DISCOVERY | 2016年 / 15卷 / 11期
关键词：
D O I：
10.1038/nrd.2016.188
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Nonalcoholic steatohepatitis (NASH), an extreme form of nonalcholic fatty liver disease, is predicted to become the leading reason for liver transplantation by 2020. This analysis provides an overview of emerging therapies for NASH.
引用
收藏
页码：745 / 746
页数：2
相关论文
共 50 条
  • [1] Nonalcoholic steatohepatitis (NASH) drugs market
    Sorcha Cassidy
    Basharut A. Syed
    Nature Reviews Drug Discovery, 2016, 15 : 745 - 746
  • [2] NASH - Nonalcoholic steatohepatitis
    Blechacz, B
    Stremmel, W
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2003, 41 (01): : 77 - 90
  • [3] Pathogenesis of nonalcoholic steatohepatitis (NASH)
    Pirlich, M
    Lochs, H
    Schmidt, HHJ
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2001, 39 (05): : 441 - 442
  • [4] Predictors of fibrosis in nonalcoholic steatohepatitis (NASH)
    Copaci, I
    Micu, L
    Cojocaru, L
    Voiculescu, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 192 - 192
  • [5] Noninvasive evaluation of nonalcoholic steatohepatitis (NASH)
    Mansour-Ghanaei, Fariborz
    Vahhabi-Moghaddam, Masrour
    Joukar, Farahnaz
    Asgharnezhad, Mehrnaz
    Kiyani, Noufar
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2013, 4 (04) : 797 - 798
  • [6] Definition and management of nonalcoholic steatohepatitis (NASH)
    Hütteroth, TH
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 : S64 - S67
  • [7] Nonalcoholic steatohepatitis (NASH): therapeutic approaches
    Buscher, HP
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 : S60 - S62
  • [8] Normal Weight Nonalcoholic Steatohepatitis (NASH)
    Samala, Niharika
    May, Kevin P.
    Kleiner, David E.
    Loomba, Rohit
    Terrault, Norah
    Neuschwander-Tetri, Brent A.
    Hoofnagle, Jay H.
    HEPATOLOGY, 2013, 58 : 495A - 495A
  • [9] Nonalcoholic steatohepatitis (NASH): Mechanism of hepatotoxic sensitivity
    Donthamsetty, S
    Bhave, VS
    Mitra, M
    Mehendale, H
    Latendresse, J
    FASEB JOURNAL, 2006, 20 (05): : A1380 - A1380
  • [10] Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH)
    Qi, Xiaoyan
    Lai, Jinping
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
12345